Home > Pressrelease > Yeast Beta Glucan Market size to reach $409 Mn by 2032

Yeast Beta Glucan Market size to reach $409 Mn by 2032

  • Published Date: February 6, 2023

Yeast Beta Glucan Market size is poised to exceed USD 409 million by 2032, according to a new research report by Global Market Insights Inc.

In the U.S., yeast beta-glucan is regarded as GRAS (Generally Recognized as Safe), a food substance that the Food and Drug Administration (FDA) considers safe and is widely used in foods, such as baking foods and beverages, premix, dairy products, cereals, and vegetable protein products. Furthermore, the rising usage of yeast beta glucan in the production of sports nutrition products is increasingly drawing interest from a growing number of health-conscious customers.

Increasing demand for natural food flavoring to favor insoluble segment

Based on form, the yeast beta glucan market from the insoluble segment is estimated to exhibit a CAGR of 10% from 2023 to 2032, owing to the increasing use of natural flavoring that is produced using yeast, coupled with prominent initiatives by various companies to launch new products. For instance, in April 2022, AIDP, Inc. stated that Puremune, a branded insoluble yeast beta-glucan by Immudyne Nutritional, received a commercial authorization from Health Canada as a yeast beta glucan source with immunomodulating effects at 30 mg per dosage.

Growing production of functional health food products to fuel above 85% segment growth

The yeast beta glucan market share from the above 85% segment is set to cross USD 95.5 million in revenue by 2032, attributed to the growing demand for food products with functional benefits among the younger generations, such as millennials, is fueling product use. Furthermore, ongoing initiatives by enterprises to consolidate their business standing are likely to promote segment expansion. In January 2021, Danstar Ferment AG, a Lallemand Inc subsidiary, acquired Biotec BetaGlucans AS (BBG), a producer of high-purity beta glucan, to gain access to promising technologies in yeast-based ingredients.

Browse key industry insights spread across 278 pages with 389 market data tables and 27 figures & charts from the report, “Yeast Beta-glucan Market Size By Form (Soluble, Insoluble), By Purity (Below 70%, 70%, 70% to 85%, Above 85%), By Application (Food & Beverage, Cosmetics, Pharmaceuticals, Animal Feed), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:


R&D initiatives to propel product application for medicinal purposes to promote pharmaceuticals industry growth

As per the report, the from pharmaceutical applications segment is anticipated to depict more than 10.5% CAGR through 2032. In recent years, pharmaceutical companies have amplified their R&D efforts to incorporate the immunity-boosting properties of yeast beta glucan in various treatments, which is expected to impel the market growth. For instance, in August 2022, Ceapro and McMaster University extended an ongoing collaboration to conduct further research on developing an inhalable immuno-therapeutic for treating lung fibrosis caused by the COVID-19 infection with yeast beta glucan that is purified and dried using PGX technology.

Escalating demand for health and wellness products to promote Europe market growth

The Europe yeast beta glucan market is slated to surpass USD 125 million by 2032. The EU has approved yeast beta-glucan as a novel food component in the manufacturing of beverages and a variety of foods. The rising popularity of health and wellness products, particularly nutritional supplements, has increased the need for yeast beta glucan, which is a major factor likely to boost the regional industry revenue growth. According to NCBI, 72% of adults in Poland use dietary supplements, with 48% consuming them on a regular basis.

Augmenting popularity of plant-based products to define the industry outlook

Some of the leading companies operating in the yeast beta glucan market include Kerry Group, Ohly, Mitushi Biopharma, Aria Ingredients, Sanofi, Biorigin, Lallemand, and Leiber. Companies are employing new technology for innovative product releases in order to expand their worldwide reach. In April 2022, Wellbeing Nutrition, an emerging plant-based nutrition firm in India, and Disney collaborated to launch the Oral Thin Strips range for kids that are 100% USDA Certified Organic and plant-based melts. It also includes Wellmune, a yeast beta glucan clinically proven to enhance children's immune systems.

Authors: Kunal Ahuja, Tushar Malkani